Skip to content

Peter Petschner

2 papers in the library · publishing 2018

Papers

Sort Most recent Most cited

Gene expression analysis indicates reduced memory and cognitive functions in the hippocampus and increase in synaptic reorganization in the frontal cortex 3 weeks after MDMA administration in Dark Agouti rats.

BMC Genomics August 2, 2018 Peter Petschner, Viola Tamasi, Csaba Ádori et al.

3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") is a widely used entactogenic drug known to impair cognitive functions on the long-run. Both hippocampal and frontal cortical regions have well established roles in behavior, memory formation and other cognitive tasks and damage of these regions is associated with altered behavior and cognitive functions frequently described in otherwise...

Downregulation of the Vitamin D Receptor Regulated Gene Set in the Hippocampus After MDMA Treatment.

Frontiers in Pharmacology 2018 Peter Petschner, Noemi Balogh, Csaba Ádori et al.

The active ingredient of ecstasy, ±3,4-methylenedioxymethamphetamine (MDMA), in addition to its initial reinforcing effects, induces selective and non-selective brain damage. Evidences suggest that the hippocampus (HC), a central region for cognition, may be especially vulnerable to impairments on the long-run, nevertheless, transcription factors that may precede and regulate such chronic...

DOI: 10.3389/fphar.2018.01373 (opens in new tab) Full text (opens in new tab) Ecstasy Gene expression Hippocampus Long-term potentiation +2